Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

First international TNBC conference meeting report.

Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R.

Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8. Review.

PMID:
29417299
2.

Severity and pattern of injuries caused by Swiss wrestling (Schwingen): first retrospective study at a level I University Emergency Department in Switzerland.

Maliachovas NK, Klukowska-Rötzler J, Sauter TC, Lehmann B, Krummrey G, Exadaktylos AK.

BMJ Open Sport Exerc Med. 2018 Jan 13;4(1):e000270. doi: 10.1136/bmjsem-2017-000270. eCollection 2018.

3.

Professionalisation rather than monopolisation is the future of emergency medicine in Europe.

Hautz WE, Sauter TC, Lehmann B, Exadaktylos AK.

Eur J Anaesthesiol. 2018 Mar;35(3):234-235. doi: 10.1097/EJA.0000000000000744. No abstract available.

4.

The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer.

Guo Y, Yu H, Wang J, Sheng Q, Zhao S, Zhao YY, Lehmann BD.

Genes (Basel). 2018 Jan 10;9(1). pii: E29. doi: 10.3390/genes9010029.

5.

Light-induced functions in DNA.

Reisacher U, Antusch L, Hofsäß R, Schwechheimer C, Lehmann B, Wagenknecht HA.

Curr Opin Chem Biol. 2017 Oct;40:119-126. doi: 10.1016/j.cbpa.2017.07.011. Epub 2017 Sep 20. Review.

PMID:
28938174
6.

Corrigendum to "Comparative Study of Exome Copy Number Variation Estimation Tools Using Array Comparative Genomic Hybridization as Control".

Guo Y, Sheng Q, Samuels DC, Lehmann B, Bauer JA, Pietenpol J, Shyr Y.

Biomed Res Int. 2017;2017:7409598. doi: 10.1155/2017/7409598. Epub 2017 Jul 18.

7.

Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.

Lehmann B, Biburger M, Brückner C, Ipsen-Escobedo A, Gordan S, Lehmann C, Voehringer D, Winkler T, Schaft N, Dudziak D, Sirbu H, Weber GF, Nimmerjahn F.

Sci Immunol. 2017 Jan 6;2(7). pii: eaah6413. doi: 10.1126/sciimmunol.aah6413.

PMID:
28783667
8.

Estimating relative mitochondrial DNA copy number using high throughput sequencing data.

Zhang P, Lehmann BD, Samuels DC, Zhao S, Zhao YY, Shyr Y, Guo Y.

Genomics. 2017 Oct;109(5-6):457-462. doi: 10.1016/j.ygeno.2017.07.002. Epub 2017 Jul 19.

PMID:
28734953
9.

Informed decision making in the context of childhood immunization.

Lehmann BA, de Melker HE, Timmermans DRM, Mollema L.

Patient Educ Couns. 2017 Dec;100(12):2339-2345. doi: 10.1016/j.pec.2017.06.015. Epub 2017 Jun 26.

10.

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.

Lehmann BA, Eilers R, Mollema L, Ferreira J, de Melker HE.

BMC Geriatr. 2017 Jun 7;17(1):122. doi: 10.1186/s12877-017-0511-7.

11.

Assessing dynamic functional connectivity in heterogeneous samples.

Lehmann BCL, White SR, Henson RN, Cam-Can, Geerligs L.

Neuroimage. 2017 Aug 15;157:635-647. doi: 10.1016/j.neuroimage.2017.05.065. Epub 2017 Jun 1.

12.

Detection of pneumothoraces in patients with multiple blunt trauma: use and limitations of eFAST.

Sauter TC, Hoess S, Lehmann B, Exadaktylos AK, Haider DG.

Emerg Med J. 2017 Sep;34(9):568-572. doi: 10.1136/emermed-2016-205980. Epub 2017 May 12.

13.

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.

Jovanović B, Sheng Q, Seitz RS, Lawrence KD, Morris SW, Thomas LR, Hout DR, Schweitzer BL, Guo Y, Pietenpol JA, Lehmann BD.

BMC Cancer. 2017 Apr 4;17(1):241. doi: 10.1186/s12885-017-3237-1.

14.

A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67.

Jovanović B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders ME, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KC, Sanchez V, Rosenbluth JM, Dillon PM, Forero-Torres A, Chang JC, Meszoely IM, Grau AM, Lehmann BD, Shyr Y, Sheng Q, Chen SC, Arteaga CL, Pietenpol JA.

Clin Cancer Res. 2017 Aug 1;23(15):4035-4045. doi: 10.1158/1078-0432.CCR-16-3055. Epub 2017 Mar 7.

PMID:
28270498
15.

The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies.

Zhang P, Lehmann BD, Shyr Y, Guo Y.

Int J Genomics. 2017;2017:1926304. doi: 10.1155/2017/1926304. Epub 2017 Jan 26. Review.

16.

A Bibliometric History of the Journal GENETICS.

Telis N, Lehmann BV, Feldman MW, Pritchard JK.

Genetics. 2016 Dec;204(4):1337-1342. Epub 2016 Dec 7. No abstract available.

17.

Shared drink and a soft punch: an almost deadly combination.

Klingberg K, Srivastava D, Bosbach S, Lehmann B.

BMJ Case Rep. 2016 Nov 29;2016. pii: bcr2016216424. doi: 10.1136/bcr-2016-216424.

PMID:
27899385
18.

[Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].

Riedel C, Lehmann B, Broich K, Sudhop T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Dec;59(12):1587-1592. Review. German.

PMID:
27778087
19.

RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining.

Guo Y, Wu J, Zhao S, Ye F, Su Y, Clark T, Sheng Q, Lehmann B, Shu XO, Cai Q.

Int J Genomics. 2016;2016:9837310. Epub 2016 Sep 28.

20.

Erratum to: Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.

Annane D, Brun-Buisson C, Cariou A, Martin C, Misset B, Renault A, Lehmann B, Millul V, Maxime V, Bellissant E; APROCCHSS Investigators for the TRIGGERSEP Network.

Ann Intensive Care. 2016 Dec;6(1):79. doi: 10.1186/s13613-016-0165-1. Epub 2016 Aug 19. No abstract available.

21.

Interprofessional and interdisciplinary simulation-based training leads to safe sedation procedures in the emergency department.

Sauter TC, Hautz WE, Hostettler S, Brodmann-Maeder M, Martinolli L, Lehmann B, Exadaktylos AK, Haider DG.

Scand J Trauma Resusc Emerg Med. 2016 Aug 2;24:97. doi: 10.1186/s13049-016-0291-7.

22.

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.

Lehmann BD, Jovanović B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA.

PLoS One. 2016 Jun 16;11(6):e0157368. doi: 10.1371/journal.pone.0157368. eCollection 2016.

23.

Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies.

Shaver TM, Lehmann BD, Beeler JS, Li CI, Li Z, Jin H, Stricker TP, Shyr Y, Pietenpol JA.

Cancer Res. 2016 Aug 15;76(16):4850-60. doi: 10.1158/0008-5472.CAN-16-0058. Epub 2016 May 26.

24.

Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial.

Annane D, Buisson CB, Cariou A, Martin C, Misset B, Renault A, Lehmann B, Millul V, Maxime V, Bellissant E; APROCCHSS Investigators for the TRIGGERSEP Network.

Ann Intensive Care. 2016 Dec;6(1):43. doi: 10.1186/s13613-016-0147-3. Epub 2016 May 6. Erratum in: Ann Intensive Care. 2016 Dec;6(1):79.

25.

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Apr 18;16:275. doi: 10.1186/s12885-016-2307-0. No abstract available.

26.

Aetiology of adult burns treated from 2000 to 2012 in a Swiss University Hospital.

Müller M, Moser EM, Pfortmueller CA, Olariu R, Lehmann B, Exadaktylos AK.

Burns. 2016 Jun;42(4):919-25. doi: 10.1016/j.burns.2016.03.005. Epub 2016 Apr 6.

PMID:
27061890
27.

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.

Ring BZ, Hout DR, Morris SW, Lawrence K, Schweitzer BL, Bailey DB, Lehmann BD, Pietenpol JA, Seitz RS.

BMC Cancer. 2016 Feb 23;16:143. doi: 10.1186/s12885-016-2198-0. Erratum in: BMC Cancer. 2016;16(1):275.

28.

Adult Asylum Seekers from the Middle East Including Syria in Central Europe: What Are Their Health Care Problems?

Pfortmueller CA, Schwetlick M, Mueller T, Lehmann B, Exadaktylos AK.

PLoS One. 2016 Feb 10;11(2):e0148196. doi: 10.1371/journal.pone.0148196. eCollection 2016.

29.

Changing the default to promote influenza vaccination among health care workers.

Lehmann BA, Chapman GB, Franssen FM, Kok G, Ruiter RA.

Vaccine. 2016 Mar 8;34(11):1389-92. doi: 10.1016/j.vaccine.2016.01.046. Epub 2016 Feb 3.

30.

Direct new oral anticoagulants in the emergency department: Experience in everyday clinical practice at a Swiss university hospital.

Sauter TC, Amylidi AL, Ricklin ME, Lehmann B, Exadaktylos AK.

Eur J Intern Med. 2016 Apr;29:e13-5. doi: 10.1016/j.ejim.2015.12.009. Epub 2016 Jan 5. No abstract available.

PMID:
26777104
31.

RNAseq by Total RNA Library Identifies Additional RNAs Compared to Poly(A) RNA Library.

Guo Y, Zhao S, Sheng Q, Guo M, Lehmann B, Pietenpol J, Samuels DC, Shyr Y.

Biomed Res Int. 2015;2015:862130. doi: 10.1155/2015/862130. Epub 2015 Oct 12.

32.

Clinical implications of molecular heterogeneity in triple negative breast cancer.

Lehmann BD, Pietenpol JA.

Breast. 2015 Nov;24 Suppl 2:S36-40. doi: 10.1016/j.breast.2015.07.009. Epub 2015 Aug 5. Review.

33.

Mitochondria sequence mapping strategies and practicability of mitochondria variant detection from exome and RNA sequencing data.

Zhang P, Samuels DC, Lehmann B, Stricker T, Pietenpol J, Shyr Y, Guo Y.

Brief Bioinform. 2016 Mar;17(2):224-32. doi: 10.1093/bib/bbv057. Epub 2015 Aug 5.

34.

Triple-negative breast cancer: molecular subtypes and new targets for therapy.

Lehmann BD, Pietenpol JA, Tan AR.

Am Soc Clin Oncol Educ Book. 2015:e31-9. doi: 10.14694/EdBook_AM.2015.35.e31.

35.

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.

Wilson AJ, Fadare O, Beeghly-Fadiel A, Son DS, Liu Q, Zhao S, Saskowski J, Uddin MJ, Daniel C, Crews B, Lehmann BD, Pietenpol JA, Crispens MA, Marnett LJ, Khabele D.

Oncotarget. 2015 Aug 28;6(25):21353-68.

36.

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments.

Mohni KN, Thompson PS, Luzwick JW, Glick GG, Pendleton CS, Lehmann BD, Pietenpol JA, Cortez D.

PLoS One. 2015 May 12;10(5):e0125482. doi: 10.1371/journal.pone.0125482. eCollection 2015.

37.

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.

Lehmann BD, Ding Y, Viox DJ, Jiang M, Zheng Y, Liao W, Chen X, Xiang W, Yi Y.

BMC Cancer. 2015 Mar 26;15:179. doi: 10.1186/s12885-015-1102-7.

38.

Medical students' attitude towards influenza vaccination.

Lehmann BA, Ruiter RA, Wicker S, Chapman G, Kok G.

BMC Infect Dis. 2015 Apr 15;15:185. doi: 10.1186/s12879-015-0929-5.

39.

At-sea trial of 24-h-based submarine watchstanding schedules with high and low correlated color temperature light sources.

Young CR, Jones GE, Figueiro MG, Soutière SE, Keller MW, Richardson AM, Lehmann BJ, Rea MS.

J Biol Rhythms. 2015 Apr;30(2):144-54. doi: 10.1177/0748730415575432.

PMID:
25838419
40.

Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.

Klier J, Lehmann B, Fuchs S, Reese S, Hirschmann A, Coester C, Winter G, Gehlen H.

J Vet Intern Med. 2015 Jan;29(1):286-93. doi: 10.1111/jvim.12524.

41.

Sociocognitive predictors of the intention of healthcare workers to receive the influenza vaccine in Belgian, Dutch and German hospital settings.

Lehmann BA, Ruiter RA, van Dam D, Wicker S, Kok G.

J Hosp Infect. 2015 Mar;89(3):202-9. doi: 10.1016/j.jhin.2014.11.009. Epub 2014 Dec 16.

42.

The intention to get vaccinated against influenza and actual vaccination uptake of Dutch healthcare personnel.

Lehmann BA, Ruiter RAC, Chapman G, Kok G.

Vaccine. 2014 Dec 5;32(51):6986-6991. doi: 10.1016/j.vaccine.2014.10.034. Epub 2014 Oct 28.

43.

Detection of internal exon deletion with exon Del.

Guo Y, Zhao S, Lehmann BD, Sheng Q, Shaver TM, Stricker TP, Pietenpol JA, Shyr Y.

BMC Bioinformatics. 2014 Oct 16;15:332. doi: 10.1186/1471-2105-15-332.

44.

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.

Lehmann BD, Bauer JA, Schafer JM, Pendleton CS, Tang L, Johnson KC, Chen X, Balko JM, Gómez H, Arteaga CL, Mills GB, Sanders ME, Pietenpol JA.

Breast Cancer Res. 2014 Aug 8;16(4):406. doi: 10.1186/s13058-014-0406-x.

45.

Subtyping of triple-negative breast cancer: implications for therapy.

Abramson VG, Lehmann BD, Ballinger TJ, Pietenpol JA.

Cancer. 2015 Jan 1;121(1):8-16. doi: 10.1002/cncr.28914. Epub 2014 Jul 16. Review.

46.

[Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE].

Lehmann B, Heimes B, Gutfleisch M, Spital G, Pauleikhoff D, Lommatzsch A.

Ophthalmologe. 2015 Jan;112(1):49-56. doi: 10.1007/s00347-014-3098-9. German.

PMID:
25033948
47.

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.

Jovanović B, Beeler JS, Pickup MW, Chytil A, Gorska AE, Ashby WJ, Lehmann BD, Zijlstra A, Pietenpol JA, Moses HL.

Breast Cancer Res. 2014 Jul 1;16(4):R69. doi: 10.1186/bcr3684.

48.
49.

Multi-perspective quality control of Illumina exome sequencing data using QC3.

Guo Y, Zhao S, Sheng Q, Ye F, Li J, Lehmann B, Pietenpol J, Samuels DC, Shyr Y.

Genomics. 2014 May-Jun;103(5-6):323-8. doi: 10.1016/j.ygeno.2014.03.006. Epub 2014 Apr 3.

50.

A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activity.

Lux A, Seeling M, Baerenwaldt A, Lehmann B, Schwab I, Repp R, Meidenbauer N, Mackensen A, Hartmann A, Heidkamp G, Dudziak D, Nimmerjahn F.

Cell Rep. 2014 Apr 10;7(1):236-48. doi: 10.1016/j.celrep.2014.02.041. Epub 2014 Mar 27.

Supplemental Content

Loading ...
Support Center